Robotic Assisted Surgery

Shares of Transenterix Inc (NYSE: TRXC) were highly volatile on Monday after the company received an update from the U.S. Food and Drug Administration. Transenterix applied for a 510(k) submission with the FDA, which would grant the company marketing clearance for its SurgiBot, a robotically...